KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors
Clinical trial NCT04237649 · TERMINATED
Trial details
- NCT number
- NCT04237649
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-20
- Primary completion
- 2023-09-15
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.